221 related articles for article (PubMed ID: 10473514)
1. Low levels of antigenic variability in fluconazole-susceptible and -resistant Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Lopez-Ribot JL; McAtee RK; Kirkpatrick WR; La Valle R; Patterson TF
Clin Diagn Lab Immunol; 1999 Sep; 6(5):665-70. PubMed ID: 10473514
[TBL] [Abstract][Full Text] [Related]
2. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.
Martínez M; López-Ribot JL; Kirkpatrick WR; Bachmann SP; Perea S; Ruesga MT; Patterson TF
J Antimicrob Chemother; 2002 Mar; 49(3):515-24. PubMed ID: 11864952
[TBL] [Abstract][Full Text] [Related]
5. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
[TBL] [Abstract][Full Text] [Related]
6. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F
Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
[TBL] [Abstract][Full Text] [Related]
7. Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients.
Revankar SG; Kirkpatrick WR; McAtee RK; Dib OP; Fothergill AW; Redding SW; Rinaldi MG; Patterson TF
J Infect Dis; 1996 Oct; 174(4):821-7. PubMed ID: 8843222
[TBL] [Abstract][Full Text] [Related]
8. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype.
Millon L; Manteaux A; Reboux G; Drobacheff C; Monod M; Barale T; Michel-Briand Y
J Clin Microbiol; 1994 Apr; 32(4):1115-8. PubMed ID: 8027327
[TBL] [Abstract][Full Text] [Related]
9. Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Lopez-Ribot JL; McAtee RK; Lee LN; Kirkpatrick WR; White TC; Sanglard D; Patterson TF
Antimicrob Agents Chemother; 1998 Nov; 42(11):2932-7. PubMed ID: 9797228
[TBL] [Abstract][Full Text] [Related]
10. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis.
Pfaller MA; Rhine-Chalberg J; Redding SW; Smith J; Farinacci G; Fothergill AW; Rinaldi MG
J Clin Microbiol; 1994 Jan; 32(1):59-64. PubMed ID: 7907345
[TBL] [Abstract][Full Text] [Related]
11. Change in fluconazole susceptibility patterns and genetic relationship among oral Candida albicans isolates.
Diaz-Guerra TM; Martinez-Suarez JV; Laguna F; Valencia E; Rodriguez-Tudela JL
AIDS; 1998 Sep; 12(13):1601-10. PubMed ID: 9764778
[TBL] [Abstract][Full Text] [Related]
12. Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis.
Barchiesi F; Hollis RJ; Del Poeta M; McGough DA; Scalise G; Rinaldi MG; Pfaller MA
Clin Infect Dis; 1995 Sep; 21(3):561-4. PubMed ID: 8527544
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
Barchiesi F; Colombo AL; McGough DA; Fothergill AW; Rinaldi MG
Antimicrob Agents Chemother; 1994 Nov; 38(11):2553-6. PubMed ID: 7872746
[TBL] [Abstract][Full Text] [Related]
14. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.
Ruhnke M; Eigler A; Tennagen I; Geiseler B; Engelmann E; Trautmann M
J Clin Microbiol; 1994 Sep; 32(9):2092-8. PubMed ID: 7814530
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
[TBL] [Abstract][Full Text] [Related]
16. Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facility.
Makarova NU; Pokrowsky VV; Kravchenko AV; Serebrovskaya LV; James MJ; McNeil MM; Lasker BA; Warnock DW; Reiss E
J Clin Microbiol; 2003 May; 41(5):1833-7. PubMed ID: 12734213
[TBL] [Abstract][Full Text] [Related]
17. Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors.
Lacassin F; Damond F; Chochillon C; Longuet P; Lebras J; Vilde JL; Leport C
Antimicrob Agents Chemother; 1996 Aug; 40(8):1961-3. PubMed ID: 8843316
[TBL] [Abstract][Full Text] [Related]
18. Oral transmission of Candida albicans between partners in HIV-infected couples could contribute to dissemination of fluconazole-resistant isolates.
Dromer F; Improvisi L; Dupont B; Eliaszewicz M; Pialoux G; Fournier S; Feuillie V
AIDS; 1997 Jul; 11(9):1095-101. PubMed ID: 9233455
[TBL] [Abstract][Full Text] [Related]
19. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
White TC; Pfaller MA; Rinaldi MG; Smith J; Redding SW
Oral Dis; 1997 May; 3 Suppl 1():S102-9. PubMed ID: 9456667
[TBL] [Abstract][Full Text] [Related]
20. Clonal and spontaneous origins of fluconazole resistance in Candida albicans.
Xu J; Ramos AR; Vilgalys R; Mitchell TG
J Clin Microbiol; 2000 Mar; 38(3):1214-20. PubMed ID: 10699025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
